布地奈德福莫特罗与布地奈德气雾剂治疗慢阻肺、肺心病的疗效比较

Comparison on Curative Effects of Budesonide Formotero and Budesonide Aerosol in the Treatment of Chronic Obstructive Pulmonary Disease and Pulmonary Heart Disease

目的比较布地奈德福莫特罗与布地奈德气雾剂治疗慢阻肺、肺心病的临床效果。方法选取我院2017年1月至2017年12月收治的110例慢阻肺、肺心病患者,随机分为研究组与对照组各55例。研究组采用布地奈德福莫特罗治疗,对照组采用布地奈德气雾剂治疗。对比两组患者的临床治疗效果。结果研究组的总有效率为94.55%,高于对照组的81.82%(P <0.05)。治疗后,研究组的FEV_1、 FEV_1/FVC、 PaO_2水平均高于对照组(P <0.05),而PaCO_2水平低于对照组(P <0.05)。治疗后,研究组的躯体功能、心理功能、物质功能、社会功能评分均高于对照组(P <0.05)。结论布地奈德福莫特罗治疗慢阻肺、肺心病的效果较好,可缓解患者的临床症状,改善其肺功能,提高生活质量,促进病情快速恢复。

Objective To compare the clinical effects of budesonide formotero and budesonide aerosol in the treatment of patients with chronic obstructive pulmonary disease and pulmonary heart disease. Methods 110 cases of patients with chronic obstructive pulmonary disease and pulmonary heart disease admitted to our hospital from January 2017 to December 2017 were selected and randomly divided into study group and control group, with 55 cases in each group. The study group was treated with budesonide formotero, while the control group was treated with budesonide aerosol. The clinical treatment effects of the two groups were compared. Results The total effective rate of the study group was 94.55%, higher than 81.82% of the control group（P 0.05）. After treatment, the FEV_1, FEV_1/FVC and PaO_2 levels of the study group were higher than those of the control group（P 0.05）, but the PaCO_2 level was lower than that of the control group（P 0.05）.After treatment, the scores of body function, mental function, material function and social function of the study group were higher than those of the control group（P 0.05）. Conclusions Budesonide formotero has better effect in the treatment of patients with chronic obstructive pulmonary disease and pulmonary heart disease, can relieve patients＇ clinical symptoms, improve the pulmonary function, improve the quality of life, and promote the rapid recovery of the disease.